Editors:
- First comprehensive overview on the different aromatase inhibitors
- Includes preclinical and clinical studies
- Gives outlook on future uses of aromatase inhibitors
- International authorship
Part of the book series: Milestones in Drug Therapy (MDT)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (9 chapters)
-
Front Matter
-
Back Matter
About this book
Many breast tumours are dependent upon oestrogen for their development and continued growth. Over the last 25 years hormone therapy has progressed from the irreversible destruction of endocrine glands to the use of drugs that reversibly suppress oestrogen synthesis or action. The inhibition of oestrogen synthesis is most readily achieved by inhibiting the final step in the pathway of oestrogen biosynthesis, the reaction which transforms androgens into oestrogens by creating an aromatic ring in the steroid molecule (hence the enzyme's trivial name, aromatase).
Whereas the first aromatase inhibitors to be used therapeutically could be shown to produce drug-induced inhibition of the enzyme and therapeutic benefits in patients with breast cancer, they were not particularly potent and lacked specificity. However, second-generation drugs were developed and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency. Initial results from clinical trials suggest that these agents will become the cornerstones of future endocrine therapy.
Editors and Affiliations
-
AstraZeneca, Global Discovery, Macclesfield, Cheshire, UK
Barrington J.A. Furr
Bibliographic Information
Book Title: Aromatase Inhibitors
Editors: Barrington J.A. Furr
Series Title: Milestones in Drug Therapy
DOI: https://doi.org/10.1007/3-7643-7418-7
Publisher: Birkhäuser Basel
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Birkhäuser Basel 2006
eBook ISBN: 978-3-7643-7418-1Published: 20 February 2006
Series ISSN: 2296-6056
Series E-ISSN: 2296-6064
Edition Number: 1
Number of Pages: IX, 182
Number of Illustrations: 30 b/w illustrations
Topics: Cancer Research, Pharmacology/Toxicology, Internal Medicine, Oncology, Cell Biology